TP53 and hepatocellular carcinoma: Functional experiments on hepatoma cell lines with wild-type p53 (Huh6 and HepG2) and mutant p53 (Huh7 and Hep3B) showed that MYBL2 suppression decreased proliferation, caused cell death, and induced similar levels of DNA damage in these cell lines.